U.S. Markets open in 2 hrs 52 mins
  • S&P Futures

    3,448.75
    +26.00 (+0.76%)
     
  • Dow Futures

    28,287.00
    +187.00 (+0.67%)
     
  • Nasdaq Futures

    11,746.75
    +96.50 (+0.83%)
     
  • Russell 2000 Futures

    1,626.80
    +15.50 (+0.96%)
     
  • Crude Oil

    40.81
    -0.02 (-0.05%)
     
  • Gold

    1,910.30
    -1.40 (-0.07%)
     
  • Silver

    24.75
    +0.05 (+0.21%)
     
  • EUR/USD

    1.1813
    +0.0040 (+0.3426%)
     
  • 10-Yr Bond

    0.7610
    0.0000 (0.00%)
     
  • Vix

    28.44
    +1.03 (+3.76%)
     
  • GBP/USD

    1.2960
    +0.0019 (+0.1477%)
     
  • USD/JPY

    105.5700
    +0.1400 (+0.1328%)
     
  • BTC-USD

    11,801.74
    +744.73 (+6.74%)
     
  • CMC Crypto 200

    239.14
    +5.47 (+2.34%)
     
  • FTSE 100

    5,891.95
    +7.30 (+0.12%)
     
  • Nikkei 225

    23,567.04
    -104.09 (-0.44%)
     

ShockWave Medical: Q2 Earnings Insights

Benzinga Insights
·1 min read

Shares of ShockWave Medical (NASDAQ:SWAV) moved higher by 1.5% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share decreased 47.37% over the past year to ($0.56), which beat the estimate of ($0.62).

Revenue of $10,286,000 rose by 2.74% from the same period last year, which beat the estimate of $8,350,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Aug 11, 2020

View more earnings on SWAV

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/i7rw4ij5

Recent Stock Performance

52-week high: $53.33

52-week low: $22.01

Price action over last quarter: Up 31.02%

Company Profile

ShockWave Medical Inc a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.